Tech Rout and Geopolitical Fog: Opening the Book in Quality Growth
A semiconductor-led technology selloff — QQQ -3.29%, XLK -4.14%, NVDA -4.13% — collided with elevated geopolitical noise on three fronts (Ukraine escalation, Senate Iran war powers, Trump oil-gouging rhetoric) to produce a -1.45% S&P 500 day. Defensives absorbed capital while quality growth showed differentiated resilience. This inaugural portfolio opens concentrated in high-conviction secular compounders: AI platform software, GLP-1 pharma, cloud infrastructure, and banking leadership, with a small-cap broadening stake as a secondary conviction.
What Happened Today
Wednesday, June 24 delivered a sharp technology-led selloff that pulled the S&P 500 down 1.45%, with the real damage concentrated in semiconductors and large-cap tech. QQQ fell 3.29% and the Technology Select Sector SPDR (XLK) lost 4.14%. NVIDIA dropped 4.13%, Broadcom gave back 3.06%, and the broader chip complex followed in sympathy.
The catalyst came partly from Cerebras Systems, which reported its first quarterly earnings since its IPO and guided for shrinking gross margins — a signal the market interpreted as evidence of pricing pressure emerging in the AI hardware stack. The reaction was swift and indiscriminate, sweeping up names whose businesses are fundamentally different from Cerebras. NVIDIA sells GPU compute to hyperscalers at supply-constrained prices with multi-quarter backlog visibility; Cerebras sells custom inference chips to enterprise customers at competitive spot pricing. The market did not distinguish between them today, which is the kind of dislocation that creates medium-term opportunity.
Geopolitical Backdrop
The selloff did not happen in a vacuum. Markets are navigating genuine geopolitical complexity on multiple simultaneous fronts.
Ukraine-Russia escalation: Ukrainian drone strikes on Moscow are raising the cost of the war for Russia and testing Putin's resolve. While eventual war termination might be read as a positive scenario for European risk assets and energy supply normalization, the near-term uncertainty keeps the geopolitical premium elevated.
Iran diplomacy in flux: The U.S. Senate backed an Iran war powers resolution today, with growing bipartisan pressure on President Trump's diplomatic efforts. The outcome has direct implications for oil prices, Strait of Hormuz transit risk, and regional stability. Simultaneously, Trump publicly accused oil companies of consumer price gouging and invoked the DOJ, a move that complicates the energy investment thesis even as crude prices firmed modestly — XLE gained +0.74% and XOM added +0.91% despite the political headwinds.
Asia-Pacific chips: MSCI confirmed South Korea retains its emerging-market classification, removing one source of index-rebalancing pressure. But Asia-Pacific semiconductor names remained under pressure following the global selloff, limiting any morning rebound.
Where Capital Went
The rotation pattern was clear: capital moved from technology and semiconductors into defensives and financials.
- Consumer Staples (XLP): +1.87% — The strongest sector on the day, a classic risk-off tell
- Healthcare (XLV): +1.41% — Benefiting from both defensive allocation and sector-specific strength
- Financials (XLF): +0.34%, JPM: +0.80% — Holding up, consistent with the ongoing institutional rotation into quality cyclicals
- Energy (XLE): +0.74%, XOM: +0.91% — Marginally positive; geopolitical supply risk provides a price floor
The notable exception within tech: Microsoft gained 1.80% on a day when QQQ fell 3.29%, outperforming the tech composite by roughly 500 basis points. This divergence matters. It suggests institutional buyers are treating MSFT as a software platform compounder rather than a rate-sensitive growth stock subject to the same margin pressures hitting hardware names.
Portfolio Positioning at Inception
This is the inaugural portfolio, opened on a day that immediately tests the conviction framework. The construction reflects three deliberate structural choices.
AI monetization is bifurcating between hardware and platform. Pure hardware plays (NVDA, AVGO) are getting re-priced for margin uncertainty as the commodity layer of AI inference becomes competitive. Platform monetizers — MSFT through Azure and Copilot seat expansion, AMZN through AWS contractual workloads — are showing greater resilience because their revenue is multi-year and contractually committed, not tied to spot chip pricing. MSFT (+1.80%) and AMZN (+0.57%) both outperformed the technology complex materially today. The book holds both at a combined 40% weight.
NVIDIA is held at 15% despite today's pressure because the core thesis is anchored in hyperscaler GPU demand, not enterprise commodity inference. AWS, Azure, and Google account for the bulk of NVIDIA's data center revenue, and none of them have signaled reduced AI infrastructure investment. The Cerebras margin miss is a signal about competition in a different product tier. That said, near-term sentiment risk is real, which is why NVDA is sized at 15% rather than 20-25%.
The GLP-1 secular growth story is structurally uncorrelated to the tech cycle. LLY's 60-day momentum (+10.43%) is the highest in the candidate universe and the stock is essentially insulated from AI hardware volatility. Obesity and diabetes volume is compounding independent of AI spending cycles, rate policy, or geopolitical risk. At 20%, LLY is the portfolio's anchor of genuine diversification.
Financial strength is the rotation vehicle. JPM is not a defensive holding — it is a quality cyclical that benefits from higher rates, robust capital markets activity, and strong consumer credit. Its 60-day momentum (+8.60%) and today's relative outperformance (+0.80% versus the S&P -1.45%) confirm that institutional rotation into financials is sustained. At 15%, it diversifies the book away from pure technology exposure without requiring a move into rate-sensitive duration.
The 10% IWM position rounds out the book as a broadening thesis — a bet that small-cap domestic businesses are beginning to participate in the economic expansion beyond mega-cap tech. Positive 60-day momentum (+6.37%) supports the positioning, and its smaller size limits the drag if the macro picture weakens.
What the Institutions Are Signaling
The 13F filings through May 2026 provide useful slow-moving context that informs but does not dictate the portfolio.
Bridgewater Associates maintains a diversified book anchored in SPY and IVV, then adds explicit AI conviction through AMZN (4.1%) and NVDA (3.7%). The read: Dalio's team sees broad market exposure as the first layer and technology as an additive conviction. Our AMZN and NVDA weights are larger because this portfolio is designed for growth leadership, not macro diversification.
Pershing Square (Ackman) holds MSFT at 15.3% and AMZN at 17.4% — among the most concentrated large-fund bets on cloud and AI infrastructure monetization in the institutional universe. The high conviction toward these two names from a concentrated, research-driven investor provides meaningful external validation for the combined 40% MSFT-AMZN weight.
Berkshire Hathaway (Buffett) is positioned in AAPL, AXP, KO, BAC, CVX — a value and dividend-quality book with minimal overlap with this portfolio's thesis. That divergence is intentional. Buffett's time horizon and capital size lead him to businesses with durable moats and cash returns; this portfolio is designed for secular compounding in the next decade of growth cycles.
Scion Asset Management (Burry) has 66% of his portfolio in Palantir, which is not available in our candidate universe, and 13.5% in NVDA — a concentrated AI data infrastructure bet. Burry's NVDA position is directionally consistent with our holding, though our sizing is more moderate given near-term margin uncertainty.
The broad institutional message: the largest allocators are not abandoning growth equities. They are discriminating within the AI trade, concentrating in platform monetizers and proven infrastructure names while the commodity hardware layer gets repriced.
What Could Break the Thesis
Four risks warrant active monitoring over the next month:
-
AI infrastructure capex guidance cuts. If Azure, AWS, or Google signal reduced data center investment in their upcoming earnings, the MSFT and AMZN theses weaken materially and NVDA loses its primary demand anchor. This is the highest-priority watch item for the AI weight in the book.
-
Iran deal breakdown and energy re-pricing. A collapse of diplomatic efforts would re-price crude upward toward levels where inflation expectations re-accelerate. That would push the Fed further out on rate cuts, compress growth multiples, and potentially require adding explicit energy exposure (XOM, XLE) to the book.
-
Geopolitical spillover into credit markets. VIX at 19.49 is elevated but not at panic levels. A move above 25 on further geopolitical escalation would signal credit stress that could force a re-evaluation of the cyclical growth weight, particularly JPM and IWM.
-
LLY pipeline setback. The GLP-1 thesis is thesis-dependent in the way that NVDA's GPU thesis is not — it is tied to specific drug candidates and regulatory outcomes. Any major clinical trial failure or unexpected safety signal in the obesity pipeline would break the LLY position directly, and there is no substitute within the candidate universe that replicates the same secular growth characteristics.
The book opens fully invested and concentrated in the highest-quality compounders available. Future sessions will evolve holdings on the basis of earnings evidence, regime signals, and institutional positioning changes — not stylistic rebalancing.